Pietras RJ - Search Results

1

Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells.

Pietras RJ, Fendly BM, Chazin VR, Pegram MD, Howell SB, Slamon DJ. Pietras RJ, et al. Oncogene. 1994 Jul;9(7):1829-38. Oncogene. 1994. PMID: 7911565

2

HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.

Pietras RJ, Arboleda J, Reese DM, Wongvipat N, Pegram MD, Ramos L, Gorman CM, Parker MG, Sliwkowski MX, Slamon DJ. Pietras RJ, et al. Oncogene. 1995 Jun 15;10(12):2435-46. Oncogene. 1995. PMID: 7784095

3

The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells.

Pegram MD, Finn RS, Arzoo K, Beryt M, Pietras RJ, Slamon DJ. Pegram MD, et al. Among authors: pietras rj. Oncogene. 1997 Jul 31;15(5):537-47. doi: 10.1038/sj.onc.1201222. Oncogene. 1997. PMID: 9247307

4

Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.

Pietras RJ, Pegram MD, Finn RS, Maneval DA, Slamon DJ. Pietras RJ, et al. Oncogene. 1998 Oct 29;17(17):2235-49. doi: 10.1038/sj.onc.1202132. Oncogene. 1998. PMID: 9811454

5

Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.

Pietras RJ, Poen JC, Gallardo D, Wongvipat PN, Lee HJ, Slamon DJ. Pietras RJ, et al. Cancer Res. 1999 Mar 15;59(6):1347-55. Cancer Res. 1999. PMID: 10096569

6

Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.

Pegram M, Hsu S, Lewis G, Pietras R, Beryt M, Sliwkowski M, Coombs D, Baly D, Kabbinavar F, Slamon D. Pegram M, et al. Oncogene. 1999 Apr 1;18(13):2241-51. doi: 10.1038/sj.onc.1202526. Oncogene. 1999. PMID: 10327070

7

Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells.

Aguilar Z, Akita RW, Finn RS, Ramos BL, Pegram MD, Kabbinavar FF, Pietras RJ, Pisacane P, Sliwkowski MX, Slamon DJ. Aguilar Z, et al. Among authors: pietras rj. Oncogene. 1999 Oct 28;18(44):6050-62. doi: 10.1038/sj.onc.1202993. Oncogene. 1999. PMID: 10557094 Free article.

8

Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells.

Márquez DC, Pietras RJ. Márquez DC, et al. Among authors: pietras rj. Oncogene. 2001 Sep 6;20(39):5420-30. doi: 10.1038/sj.onc.1204729. Oncogene. 2001. PMID: 11571639

9

Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.

Li D, Williams JI, Pietras RJ. Li D, et al. Among authors: pietras rj. Oncogene. 2002 Apr 25;21(18):2805-14. doi: 10.1038/sj.onc.1205410. Oncogene. 2002. PMID: 11973639

10

Interactions between estrogen and growth factor receptors in human breast cancers and the tumor-associated vasculature.

Pietras RJ. Pietras RJ. Breast J. 2003 Sep-Oct;9(5):361-73. doi: 10.1046/j.1524-4741.2003.09510.x. Breast J. 2003. PMID: 12968955 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters